Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Smaletz O, Scher H, Small E, Verbel D, McMillan A, Regan K
. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol. 2002; 20(19):3972-82.
DOI: 10.1200/JCO.2002.11.021.
View
2.
Wang Z, Shen H, Ma N, Li Q, Mao Y, Wang C
. The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis. Front Oncol. 2021; 10:572590.
PMC: 7793884.
DOI: 10.3389/fonc.2020.572590.
View
3.
Halabi S, Small E, Kantoff P, Kattan M, Kaplan E, Dawson N
. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003; 21(7):1232-7.
DOI: 10.1200/JCO.2003.06.100.
View
4.
Kattan M
. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst. 2003; 95(9):634-5.
DOI: 10.1093/jnci/95.9.634.
View
5.
Walker E, Hernandez A, Kattan M
. Meta-analysis: Its strengths and limitations. Cleve Clin J Med. 2008; 75(6):431-9.
DOI: 10.3949/ccjm.75.6.431.
View